Pharmaceutical intermediates
Eluxadoline Intermediates
10 pharmaceutical intermediates for Eluxadoline. Indication: Constipation.
About Eluxadoline
- Originator
- Actavis; Janssen Pharmaceuticals
- Indication
- Constipation
- Approved Date
- 05/27/2015
- DS/DP
- 07/07/2028
Available intermediates
10 intermediates currently listed for Eluxadoline. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| L-Serine | 56-45-1 | / | / |
| L-Serine methyl ester hydrochloride | 5680-80-8 | / | / |
| Boc-L-serine methyl ester | 2766-43-0 | / | / |
| BOC-SER(TOS)-OCH3 | 56926-94-4 | / | / |
| Boc-Beta-iodo-Ala-Ome | 93267-04-0 | / | / |
| 4-(Aminocarbonyl)-N-[(1,1-dimethylethoxy)carbonyl]-2,6-dimethyl-L-phenylalanine | 623950-02-7 | / | / |
| L-Alanine, N-[(phenylmethoxy)carbonyl]-, 2-oxo-2-phenylethyl ester | 6530-41-2 | / | / |
| Carbamic acid, [(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]-, phenylmethyl ester oxalate | 1993394-57-2 | / | / |
| (S)-1-(4-Phenyl-1H-imidazol-2-yl)ethanamine | 864825-23-0 | / | / |
| Methyl 5-formyl-2-methoxybenzoate | 78515-16-9 | / | / |
Building toward Eluxadoline?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →